London Strategy attended the FT Global Pharmaceutical and Biotechnology Conference. The FT Global Pharmaceutical and Biotechnology Conference is an essential annual event for industry professionals working in key areas such as corporate strategy, drug discovery, clinical trials, market access, and supply chain management.
In November 2021, three-day event executives around the world provided insights into what it's like running a pharma company in a world transformed by a crisis. In-depth panel discussions addressed key questions facing the sector as they helped shape a new healthcare era. How can pharma companies become more patient-centric? What does the rise of ESG mean for the sector? How has the pandemic affected attitudes towards public-private partnerships?
